Learning Objectives:

1.  Understand the definitions of different forms of status epilepticus.

2.  Apply the results of the ESETT trial to the management of status patients.

3.  Review potential therapies for refractory and super-refractory status epilepticus.

Session date: 
07/09/2024 - 8:00am to 9:00am CDT
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Thomas Bleck, MD MCCM FNCS